Relay Therapeutics Inc
(RLAY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RLAY | ELVN | AMLX | ||
| Company | Relay Therapeutics Inc | Enliven Therapeutics Inc | Amylyx Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 9.14 | 28.30 | 14.47 | ||
| High | 9.32 | 28.60 | 14.77 | ||
| Low | 8.82 | 26.73 | 14.05 | ||
| Latest | 8.94 | 27.62 | 14.36 | ||
| Change | -0.21 | -0.39 | +0.01 | ||
| % Change | -2.30% | -1.39% | +0.07% | ||
| Volume | 686,654 | 33,849 | 54,891 | ||
| 20-Day Average Volume | 2,555,209 | 890,015 | 1,530,686 | ||
| Previous Close | 9.15 | 28.01 | 14.35 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 8.12 | 26.99 | 14.76 | ||
| 20-Day Raw Stochastic | 90.53% | 50.00% | 29.89% | ||
| 20-Day Relative Strength | 59.25 | 58.82 | 51.91 | ||
| Weighted Alpha | +190.55 | -2.93 | +205.25 | ||
| Today's Opinion | 100% Buy | 100% Buy | 72% Buy | ||
| Previous Opinion | 96% Buy | 100% Buy | 72% Buy | ||
| Last Month's Opinion | 88% Buy | 8% Buy | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +11.23% since 02/05/26 | +0.98% since 02/05/26 | +10.08% since 02/05/26 | ||
| Low | 8.33 on 02/06/26 | 26.43 on 02/11/26 | 13.27 on 02/06/26 | ||
| High | 9.28 on 02/12/26 | 30.22 on 02/06/26 | 15.11 on 02/10/26 | ||
| 1-Month | |||||
| %Chg | +16.22% since 01/12/26 | +8.89% since 01/12/26 | +15.42% since 01/12/26 | ||
| Low | 7.01 on 01/20/26 | 24.29 on 01/15/26 | 12.08 on 01/13/26 | ||
| High | 9.28 on 02/12/26 | 30.22 on 02/06/26 | 17.49 on 01/22/26 | ||
| 3-Month | |||||
| %Chg | +46.92% since 11/12/25 | +34.26% since 11/12/25 | +15.98% since 11/12/25 | ||
| Low | 6.04 on 11/13/25 | 14.78 on 01/06/26 | 10.83 on 01/05/26 | ||
| High | 9.28 on 02/12/26 | 30.22 on 02/06/26 | 17.49 on 01/22/26 | ||
| 6-Month | |||||
| %Chg | +170.60% since 08/12/25 | +44.28% since 08/12/25 | +74.39% since 08/12/25 | ||
| Low | 3.31 on 08/21/25 | 14.78 on 01/06/26 | 7.63 on 08/19/25 | ||
| High | 9.28 on 02/12/26 | 30.22 on 02/06/26 | 17.49 on 01/22/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,585,896 | 1,662,310 | 1,575,917 | ||
| Shares Outstanding, K | 173,322 | 59,347 | 109,820 | ||
| Annual Sales | 10,010,000 | 0 | 87,370,000 | ||
| Annual Net Income | -337,710,000 | -89,020,000 | -301,740,000 | ||
| Last Quarter Sales | 680,000 | 0 | 0 | ||
| Last Quarter Net Income | -70,380,000 | -20,150,000 | -34,390,000 | ||
| 60-Month Beta | 1.59 | 0.34 | -0.31 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.43 on 11/06/25 | -0.32 on 11/12/25 | -0.37 on 11/06/25 | ||
| Latest Earnings Date | 02/25/26 | 03/12/26 | 03/03/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | 03/28/18 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||